TP53 and cancer: UBE2D enzymes are critical in several cellular pathways involved in cancer progression, including NF-κB, TGFβ and p53 (discussed in this review) and there is abundant evidence in the literature showing dysregulation of UBE2D enzymes in multiple cancer types (reviewed by Zhou et al., 2020).